Navigation Links
BBIC – A SOY-based Substance Treats Multiple Sclerosi

Bowmann-Birk Inhibitor Concentrate (BBIC) is a natural soy-based substance. A US based study finds: BBIC improves the condition of animals with a disease similar to multiple// sclerosis.

A group of animals with Autoimmune Encephalomyelitis (EAE) received BBIC, while another group of animals also suffering from the same disease received a placebo.

"Animals that received BBIC were able to walk, while those that didn't get the drug were not," said the study leader Dr. A.M. Rostami, professor and chairperson of the department of Neurology at Jefferson Medical College in Philadelphia.

The animals that received BBIC were able to walk though with some limp or weakness. Although they were’nt completely cured, the results are promising, the researchers said.

It was also found that the CNS of the animals that received BBIC had "significantly less inflammation and demyelination" than animals that hadn't received BBIC.

"It's the first time that BBIC has been used in an EAE model and has shown significant disease suppression, and we hope it can eventually be used in humans," Rostami said.

BBIC inhibits secretion of Proteases, a group of enzymes that are responsible for the inflammation and demyelination associated with multiple sclerosis (MS), a condition which causes inflammation in the myelin coating of nerve fibers.
PRI
'"/>




Page: 1

Related medicine news :

1. Substance abuse linked to adult antisocial syndrome
2. UV- Light Tanning As A Type Of Substance-Related Disorder
3. Homeless People More Prone To Substance Abuse
4. Substance Abuse Prevention Messages Better Received Among Teenagers in the Form of Media Campaigns and Curriculum
5. Using Herbal Products Heightens Substance Abuse Risk in Teens
6. Healthcare Worker Arrested For Administering Noxious Substances
7. Better Screening Now Possible For ADHD In Adult Substance Users
8. More Medicines Found To Contain Toxic Substance
9. Substance P May Pre-empt VIP in Regulating Temperature
10. Fact Sheet on Polonium-210 - The Substance That Killed Former Russian Spy
11. Natural Brain Substance Linked to Parkinsons Symptoms
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2017)... WINTER PARK, FL (PRWEB) , ... May 20, 2017 , ... ... now sell it, find it, review it, and share its attributes like never before. ... online dispensary directory to connect cannabis enthusiasts to stores, strains, products – and for ...
(Date:5/21/2017)... , ... May 21, 2017 , ... Following the tragic ... York became the first state to require that hospitals follow a protocol to quickly ... the medical community as to whether such steps would have saved Rory or anyone ...
(Date:5/19/2017)... ... May 19, 2017 , ... DMG Productions is ... of Innovations with Ed Begley, Jr., airing fourth quarter 2017 on FOX Business. ... clean, organic dietary supplement made from naturally occurring ingredients. Innovations will enlighten viewers ...
(Date:5/19/2017)... FL (PRWEB) , ... May 19, 2017 , ... ... asset protection services and retirement planning assistance to families and business owners in ... Sclerosis Society to advocate for MS sufferers and their families. , Multiple sclerosis ...
(Date:5/19/2017)... , ... May 18, 2017 , ... ML Billing, ... all specialties and sizes and specializes in large group practices, is pleased to announce ... but it has also set the standard in all aspects of full-service medical billing. ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... Global Health Intelligence (GHI), the leading ... , published its 2017 ranking of the Best-Equipped Hospitals ... data analysis from GHI,s hospitals database for Latin America ... region. The GHI database covers 86% of the hospitals in ... data points for each institution in key areas such as ...
(Date:5/10/2017)... BURNIE, Md. , May 10, 2017 ... retention solutions for the clinical research industry, is proud ... www.CSSiEnroll.com . The new website features both enriched ... overall user experience and enhances the company,s already well-established ... the industry. "After many months of ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals Inc. ... a clinical-stage pharmaceutical company focused on the development ... the Canadian Intellectual Property Office has granted Oramed ... Administration of Exenatide". The patent covers Oramed,s invention ... GLP-1 is an incretin hormone that stimulates ...
Breaking Medicine Technology: